Omega Fund Iv Gp, L.p. - Net Worth and Insider Trading
Omega Fund Iv Gp, L.p. Net Worth
The estimated net worth of Omega Fund Iv Gp, L.p. is at least $257 Million dollars as of 2024-11-29. Omega Fund Iv Gp, L.p. is the 10% Owner of Replimune Group Inc and owns about 9,436,760 shares of Replimune Group Inc (REPL) stock worth over $133 Million. Omega Fund Iv Gp, L.p. is also the 10% Owner of Nuvation Bio Inc and owns about 22,957,340 shares of Nuvation Bio Inc (NUVB) stock worth over $125 Million. Details can be seen in Omega Fund Iv Gp, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Omega Fund Iv Gp, L.p. has not made any transactions after 2022-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Omega Fund Iv Gp, L.p.
Omega Fund Iv Gp, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Omega Fund Iv Gp, L.p. owns 5 companies in total, including Replimune Group Inc (REPL) , Translate Bio Inc (TBIO) , and Kezar Life Sciences Inc (KZR) among others .
Click here to see the complete history of Omega Fund Iv Gp, L.p.’s form 4 insider trades.
Insider Ownership Summary of Omega Fund Iv Gp, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REPL | Replimune Group Inc | 2022-03-16 | 10 percent owner |
| TBIO | Translate Bio Inc | 2018-07-02 | 10 percent owner |
| KZR | Kezar Life Sciences Inc | 2018-06-20 | 10 percent owner |
 | | 2014-10-30 | 10 percent owner |
| | 2021-12-15 | 10 percent owner |
Omega Fund Iv Gp, L.p. Latest Holdings Summary
Omega Fund Iv Gp, L.p. currently owns a total of 2 stocks. Among these stocks, Omega Fund Iv Gp, L.p. owns 9,436,760 shares of Replimune Group Inc (REPL) as of March 16, 2022, with a value of $133 Million and a weighting of 51.52%. Omega Fund Iv Gp, L.p. also owns 22,957,340 shares of Nuvation Bio Inc (NUVB) as of December 15, 2021, with a value of $125 Million and a weighting of 48.48%.
Latest Holdings of Omega Fund Iv Gp, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REPL | Replimune Group Inc | 2022-03-16 | 9,436,760 | 14.05 | 132,586,478 |
| NUVB | Nuvation Bio Inc | 2021-12-15 | 22,957,340 | 5.44 | 124,773,143 |
Holding Weightings of Omega Fund Iv Gp, L.p.
Omega Fund Iv Gp, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Omega Fund Iv Gp, L.p. has made a total of 14 transactions in Replimune Group Inc (REPL) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Replimune Group Inc is the sale of 106,500 shares on March 16, 2022, which brought Omega Fund Iv Gp, L.p. around $2 Million.
According to the SEC Form 4 filings, Omega Fund Iv Gp, L.p. has made a total of 1 transactions in Nuvation Bio Inc (NUVB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Nuvation Bio Inc is the sale of 500,000 shares on December 15, 2021, which brought Omega Fund Iv Gp, L.p. around $5 Million.
Insider Trading History of Omega Fund Iv Gp, L.p.
- 1
Omega Fund Iv Gp, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Omega Fund Iv Gp, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Omega Fund Iv Gp, L.p. is 9.6%. GuruFocus also compares Omega Fund Iv Gp, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Omega Fund Iv Gp, L.p. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Omega Fund Iv Gp, L.p.'s insider trading performs compared to the benchmark.
Performance of Omega Fund Iv Gp, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.68 | | | | | |
| Relative Return to S&P 500(%) | 13.62 | | | | | |
Omega Fund Iv Gp, L.p. Ownership Network
Omega Fund Iv Gp, L.p. Owned Company Details
What does Replimune Group Inc do?
Who are the key executives at Replimune Group Inc?
Omega Fund Iv Gp, L.p. is the 10 percent owner of Replimune Group Inc. Other key executives at Replimune Group Inc include Chief Commercial Officer Christopher Sarchi , Chief Medical Officer Konstantinos Xynos , and Chief Financial Officer Emily Luisa Hill .
Replimune Group Inc (REPL) Insider Trades Summary
Over the past 18 months, Omega Fund Iv Gp, L.p. made no insider transaction in Replimune Group Inc (REPL). Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 45,658 shares made by Pamela Esposito , a net sale of 36,807 shares made by Konstantinos Xynos , and a net sale of 12,680 shares made by Christopher Sarchi .
In summary, during the past 3 months, insiders sold 12,453 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 12,453 shares. During the past 18 months, 212,140 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 212,140 shares.
Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Replimune Group Inc Insider Transactions
Omega Fund Iv Gp, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Omega Fund Iv Gp, L.p.. You might contact Omega Fund Iv Gp, L.p. via mailing address: 888 Boylston St., Suite 1111, Boston Ma 02199.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
